The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
Retreat at Kleivstua 2018
Feb. 22, 2018 12:51 PM
All J CoDiRC members, associated members, Scientific Advisory Board and Patient Advisory Council enjoyed a two-day seminar at Kleivstua February 13-14 to present and discuss current research on coeliac disease in the Centre.
Det Glutenfrie Verksted donates money to Ludvig M. Sollid and Knut E.A. Lundin for research on coeliac disease
Nov. 28, 2017 2:33 PM
In a press release today Monica Hellmann, who is the founder of Det Glutenfrie Verksted, Nordic Refreshment Company AS, announces that she wants to donate money for the research of Professors Ludvig M. Sollid and Knut E.A. Lundin on coeliac disease.
- Outcome measures in coeliac disease trials: the Tampere recommendations Feb. 15, 2018 10:00 AM
- Efficacy of infliximab biosimilars in patients with Crohn's disease - Authors' reply Dec. 7, 2017 10:00 AM
- HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption Nov. 18, 2017 10:00 AM